Abstract
Proteolytic Activity Matrix Analysis (PrAMA) is a method for simultaneously determining the activities of specific Matrix Metalloproteinases (MMPs) and A Disintegrin and Metalloproteinases (ADAMs) in complex biological samples. In mixtures of unknown proteases, PrAMA infers selective metalloproteinase activities by using a panel of moderately specific FRET-based polypeptide protease substrates in parallel, typically monitored by a plate-reader in a 96-well format. Fluorescence measurements are then quantitatively compared to a standard table of catalytic efficiencies measured from purified mixtures of individual metalloproteinases and FRET substrates. Computational inference of specific activities is performed with an easily used Matlab program, which is provided herein. Thus, we describe PrAMA as a combined experimental and mathematical approach to determine real-time metalloproteinase activities, which has previously been applied to live-cell cultures, cellular lysates, cell culture supernatants, and body fluids from patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
* Prepare all solutions using ultrapure water and anlytical grade reagents, store as indicated.
References
Kleiner DE, Stetler-Stevenson WG (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218(2):325–329
Lauer-Fields JL, Nagase H, Fields GB (2004) Development of a solid-phase assay for analysis of matrix metalloproteinase activity. J Biomol Tech 15(4):305–316
Gosalia DN, Denney WS, Salisbury CM, Ellman JA, Diamond SL (2006) Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray. Biotechnol Bioeng 94(6):1099–1110
Sieber SA, Niessen S, Hoover HS, Cravatt BF (2006) Proteomic profiling of metalloprotease activities with cocktails of active-site probes. Nat Chem Biol 2(5):274–281
Miller MA, Barkal L, Jeng K et al (2011) Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities. Integr Biol (Camb) 3(4):422–438
Dang M, Armbruster N, Miller MA et al (2013) Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways. Proc Natl Acad Sci U S A 110(24):9776–9781
Schlomann U, Koller G, Conrad C et al (2015) ADAM8 as a drug target in pancreatic cancer. Nat Commun 6:6175
Chen CH, Miller MA, Sarkar A et al (2013) Multiplexed protease activity assay for low-volume clinical samples using droplet-based microfluidics and its application to endometriosis. J Am Chem Soc 135(5):1645–1648
Miller MA, Meyer AS, Beste MT et al (2013) ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc Natl Acad Sci U S A 110(22):E2074–E2083
Miller MA, Oudin MJ, Sullivan RJ et al (2016) Reduced proteolytic shedding of receptor tyrosine kinases is a post-translational mechanism of kinase inhibitor resistance. Cancer Discov 6(4):382–399
Miller MA, Moss ML, Powell G et al (2015) Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain. Sci Rep 5:15150
Ng EX, Miller MA, Jing T, Lauffenburger DA, Chen CH (2015) Low-volume multiplexed proteolytic activity assay and inhibitor analysis through a pico-injector array. Lab Chip 15(4):1153–1159
Ng EX, Miller MA, Jing T, Chen CH (2016) Single cell multiplexed assay for proteolytic activity using droplet microfluidics. Biosens Bioelectron 81:408–414
Moss ML, Rasmussen FH (2007) Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening. Anal Biochem 366(2):144–148
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Conrad, C., Miller, M.A., Bartsch, J.W., Schlomann, U., Lauffenburger, D.A. (2017). Simultaneous Detection of Metalloprotease Activities in Complex Biological Samples Using the PrAMA (Proteolytic Activity Matrix Assay) Method. In: Schilling, O. (eds) Protein Terminal Profiling. Methods in Molecular Biology, vol 1574. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6850-3_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6850-3_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6849-7
Online ISBN: 978-1-4939-6850-3
eBook Packages: Springer Protocols